OCUMENSION-B

01477

Current ValuationThe current P/E ratio is -27.22, below the reasonable range, cheaper than 88.04% of the time in the past 5 years, and the industry ranks 48/52, the industry Median 6.69.

-27.22xP/E
Stock priceHK$4.83Earnings per shareHK$-0.18

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.69x
09182736

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.69x
0x20x40x60x80x100x
P/E ratio
Name/Symbol
06887HKSUNSHINE PHARMA
-67.82x--HK$22.25B
02630HKVIGONVITA-B
-36.58x--HK$12.84B
00570HKTRAD CHI MED
-5.09x223.71%HK$5.92B
09637HKALEBUND-B
-7.10x48.51%HK$5.75B
02575HKXUANZHUBIO-B
-17.37x--HK$4.20B
01477HKOCUMENSION-B
-27.22x52.83%HK$3.93B
01349HKFUDANZHANGJIANG
-20.20x--HK$2.43B
02552HKHUA MEDICINE-B
-18.99x104.78%HK$2.36B
02652HKCF PHARMTECH
-279.87x--HK$2.19B
06622HKZHAOKE OPHTH-B
-4.48x--HK$1.11B
01652HKFUSEN PHARM
-275.15x--HK$735.60M
01011HKNT PHARMA
-10.02x--HK$317.99M
01643HKMODERN CHI MED
-5.00x--HK$241.20M
00575HKREGENT PACIFIC
-15.74x--HK$240.75M
00455HKTIANDA PHARMA
-2.77x--HK$191.35M
08329HKNEP INTERLONG
-3.09x--HK$187.94M
01312HKKONTA CHINA
-0.71x--HK$150.89M
00858HKEXTRAWELL PHAR
-0.13x--HK$124.70M
01498HKPURAPHARM
-4.46x--HK$123.26M
01889HKSANAI HEALTH GP
-1.22x--HK$27.37M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.